FDA DrugClass INotable

FDA Recall: DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile,

Date: 2026-06-17
Brand: SUN PHARMACEUTICAL INDUSTRIES INC
Category: Drug
FDA Class: Class I

Description

Presence of Particulate matter: Particulate matter identified as glass.

Hazard

Presence of Particulate matter: Particulate matter identified as glass.

Remedy

675 vials

Related Recalls